Published in Arch Intern Med on March 24, 2008
The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology (2013) 3.89
Ethnicity and health disparities in alcohol research. Alcohol Res Health (2010) 2.14
The role of alcohol and smoking in pancreatitis. Nat Rev Gastroenterol Hepatol (2010) 1.67
Prospective Study of Alcohol Drinking, Smoking, and Pancreatitis: The Multiethnic Cohort. Pancreas (2016) 1.43
Alcoholic liver disease-related mortality in the United States: 1980-2003. Am J Gastroenterol (2010) 1.32
American Pancreatic Association Practice Guidelines in Chronic Pancreatitis: evidence-based report on diagnostic guidelines. Pancreas (2014) 1.30
Chronic liver disease in the Hispanic population of the United States. Clin Gastroenterol Hepatol (2011) 1.30
Cellular and mitochondrial effects of alcohol consumption. Int J Environ Res Public Health (2010) 1.22
The incidence of acute pancreatitis: impact of social deprivation, alcohol consumption, seasonal and demographic factors. Aliment Pharmacol Ther (2013) 1.15
Mechanisms of alcohol-induced endoplasmic reticulum stress and organ injuries. Biochem Res Int (2011) 1.14
Incidence and mortality of acute and chronic pancreatitis in the Netherlands: a nationwide record-linked cohort study for the years 1995-2005. World J Gastroenterol (2013) 1.08
Analyses of hospital administrative data that use diagnosis codes overestimate the cases of acute pancreatitis. Clin Gastroenterol Hepatol (2012) 1.06
Alcohol abuse, endoplasmic reticulum stress and pancreatitis. Dig Dis (2011) 1.01
Definition, epidemiology and magnitude of alcoholic hepatitis. World J Hepatol (2011) 0.99
Quality of life assessment in patients with chronic pancreatitis receiving antioxidant therapy. World J Gastroenterol (2010) 0.95
In vitro and in vivo models of acute alcohol exposure. World J Gastroenterol (2009) 0.93
Drug-induced acute pancreatitis: a review. Ochsner J (2015) 0.91
β-catenin is essential for ethanol metabolism and protection against alcohol-mediated liver steatosis in mice. Hepatology (2012) 0.91
Hospitalizations for chronic pancreatitis in Allegheny County, Pennsylvania, USA. Pancreatology (2011) 0.85
Alcohol consumption on pancreatic diseases. World J Gastroenterol (2013) 0.84
Design, synthesis, and characterization of novel apigenin analogues that suppress pancreatic stellate cell proliferation in vitro and associated pancreatic fibrosis in vivo. Bioorg Med Chem (2014) 0.83
Inverse relationship between moderate alcohol intake and rectal cancer: analysis of the North Carolina Colon Cancer Study. Dis Colon Rectum (2011) 0.83
Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease. World J Gastroenterol (2014) 0.83
National hospital volume in acute pancreatitis: analysis of the Nationwide Inpatient Sample 1998-2006. HPB (Oxford) (2009) 0.79
Ethnic differences in presentation and severity of alcoholic liver disease. Alcohol Clin Exp Res (2015) 0.79
Epidural anesthesia improves pancreatic perfusion and decreases the severity of acute pancreatitis. World J Gastroenterol (2015) 0.79
Alcoholism and critical illness: A review. World J Crit Care Med (2016) 0.79
Binge ethanol exposure causes endoplasmic reticulum stress, oxidative stress and tissue injury in the pancreas. Oncotarget (2016) 0.79
Racial Differences in the Clinical Profile, Causes, and Outcome of Chronic Pancreatitis. Am J Gastroenterol (2016) 0.78
Case-fatality from acute pancreatitis is decreasing but its population mortality shows little change. Pancreatology (2016) 0.78
Effects of Clostridium difficile infection in patients with alcoholic hepatitis. Clin Gastroenterol Hepatol (2014) 0.78
Clinical Profile, Etiology, and Treatment of Chronic Pancreatitis in North American Women: Analysis of a Large Multicenter Cohort. Pancreas (2016) 0.77
Alcoholic pancreatitis: A tale of spirits and bacteria. World J Gastrointest Pathophysiol (2014) 0.77
Acute recurrent pancreatitis: Etiopathogenesis, diagnosis and treatment. World J Gastroenterol (2014) 0.76
Acute necrotizing pancreatitis as first manifestation of primary hyperparathyroidism. World J Gastroenterol (2010) 0.76
Chronic plus binge ethanol exposure causes more severe pancreatic injury and inflammation. Toxicol Appl Pharmacol (2016) 0.76
Alcoholic hepatitis and HCV interactions in the modulation of liver disease. J Viral Hepat (2015) 0.76
Relationship Between Acute Benzodiazepine Poisoning and Acute Pancreatitis Risk: A Population-Based Cohort Study. Medicine (Baltimore) (2015) 0.75
Prognostic models for alcoholic hepatitis. Biomark Res (2015) 0.75
Clusterin and Pycr1 alterations associate with strain and model differences in susceptibility to experimental pancreatitis. Biochem Biophys Res Commun (2016) 0.75
Dietary Factors Reduce Risk of Acute Pancreatitis in a Large Multiethnic Cohort. Clin Gastroenterol Hepatol (2016) 0.75
Hypertriglyceridemia, an important and independent risk factor for acute pancreatitis in patients with type 2 diabetes mellitus. Ther Clin Risk Manag (2017) 0.75
Racial/ethnic differences in 30-year trajectories of heavy drinking in a nationally representative U.S. sample. Drug Alcohol Depend (2016) 0.75
Pathogenic mechanisms of pancreatitis. World J Gastrointest Pharmacol Ther (2017) 0.75
Racial differences in parenting style typologies and heavy episodic drinking trajectories. Health Psychol (2014) 0.75
Food-Induced Acute Pancreatitis. Dig Dis Sci (2017) 0.75
Trends in alcohol-related admissions to hospital by age, sex and socioeconomic deprivation in England, 2002/03 to 2013/14. BMC Public Health (2017) 0.75
New consensus nomenclature for mammalian keratins. J Cell Biol (2006) 3.27
'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments. Curr Opin Cell Biol (2002) 3.00
Risk of perforation from a colonoscopy in adults: a large population-based study. Gastrointest Endosc (2009) 2.78
From Mallory to Mallory-Denk bodies: what, how and why? Exp Cell Res (2007) 2.61
Panhematin provides a therapeutic benefit in experimental pancreatitis. Gut (2010) 2.23
CD73 (ecto-5'-nucleotidase) hepatocyte levels differ across mouse strains and contribute to mallory-denk body formation. Hepatology (2013) 2.04
Attrition bias in rheumatoid arthritis databanks: a case study of 6346 patients in 11 databanks and 65,649 administrations of the Health Assessment Questionnaire. J Rheumatol (2004) 1.91
Underrepresentation of underrepresented minorities in academic medicine: the need to enhance the pipeline and the pipe. Gastroenterology (2009) 1.91
Cellular integrity plus: organelle-related and protein-targeting functions of intermediate filaments. Trends Cell Biol (2005) 1.89
Sphingosylphosphorylcholine regulates keratin network architecture and visco-elastic properties of human cancer cells. Nat Cell Biol (2003) 1.84
A novel composite endpoint to evaluate the gastrointestinal (GI) effects of nonsteroidal antiinflammatory drugs through the entire GI tract. J Rheumatol (2009) 1.81
Energy determinants GAPDH and NDPK act as genetic modifiers for hepatocyte inclusion formation. J Cell Biol (2011) 1.72
A disease- and phosphorylation-related nonmechanical function for keratin 8. J Cell Biol (2006) 1.68
Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury. PLoS One (2008) 1.67
Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma. Gastroenterology (2006) 1.54
Proton pump inhibitors for gastroduodenal damage related to nonsteroidal anti-inflammatory drugs or aspirin: twelve important questions for clinical practice. Clin Gastroenterol Hepatol (2009) 1.48
Studying simple epithelial keratins in cells and tissues. Methods Cell Biol (2004) 1.43
Keratin 8/18 breakdown and reorganization during apoptosis. Exp Cell Res (2004) 1.42
Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis. Circulation (2004) 1.40
Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3,763 patients with rheumatoid arthritis. Arthritis Rheum (2003) 1.40
Keratin-8-deficient mice develop chronic spontaneous Th2 colitis amenable to antibiotic treatment. J Cell Sci (2005) 1.39
Keratin 8 phosphorylation by protein kinase C delta regulates shear stress-mediated disassembly of keratin intermediate filaments in alveolar epithelial cells. J Biol Chem (2005) 1.38
Keratins let liver live: Mutations predispose to liver disease and crosslinking generates Mallory-Denk bodies. Hepatology (2007) 1.37
Absence of keratin 19 in mice causes skeletal myopathy with mitochondrial and sarcolemmal reorganization. J Cell Sci (2007) 1.34
Keratin binding to 14-3-3 proteins modulates keratin filaments and hepatocyte mitotic progression. Proc Natl Acad Sci U S A (2002) 1.32
Hemin-activated macrophages home to the pancreas and protect from acute pancreatitis via heme oxygenase-1 induction. J Clin Invest (2005) 1.31
Keratin 20 helps maintain intermediate filament organization in intestinal epithelia. Mol Biol Cell (2003) 1.29
Autophagy activation by rapamycin eliminates mouse Mallory-Denk bodies and blocks their proteasome inhibitor-mediated formation. Hepatology (2008) 1.29
Keratin variants predispose to acute liver failure and adverse outcome: race and ethnic associations. Gastroenterology (2010) 1.28
Keratin 8 phosphorylation by p38 kinase regulates cellular keratin filament reorganization: modulation by a keratin 1-like disease causing mutation. J Biol Chem (2002) 1.25
Keratins as susceptibility genes for end-stage liver disease. Gastroenterology (2005) 1.24
The intermediate filament protein keratin 8 is a novel cytoplasmic substrate for c-Jun N-terminal kinase. J Biol Chem (2002) 1.23
Keratin mutation in transgenic mice predisposes to Fas but not TNF-induced apoptosis and massive liver injury. Hepatology (2003) 1.21
Acknowledging joint first authors of published work: the time has come. Gastroenterology (2012) 1.19
Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease. Hepatology (2004) 1.19
Keratins modulate colonocyte electrolyte transport via protein mistargeting. J Cell Biol (2004) 1.18
Cytoskeletal keratin glycosylation protects epithelial tissue from injury. Nat Cell Biol (2010) 1.18
Use of health care resources and cost of care for adults with constipation. Clin Gastroenterol Hepatol (2007) 1.17
Golimumab for rheumatoid arthritis. Cochrane Database Syst Rev (2010) 1.16
Gender dimorphic formation of mouse Mallory-Denk bodies and the role of xenobiotic metabolism and oxidative stress. Gastroenterology (2010) 1.14
Keratin variants associate with progression of fibrosis during chronic hepatitis C infection. Hepatology (2006) 1.14
Risk of serious NSAID-related gastrointestinal events during long-term exposure: a systematic review. Med J Aust (2006) 1.13
Functional analysis of the human papillomavirus type 16 E1=E4 protein provides a mechanism for in vivo and in vitro keratin filament reorganization. J Virol (2004) 1.10
Type II keratins are phosphorylated on a unique motif during stress and mitosis in tissues and cultured cells. Mol Biol Cell (2002) 1.09
Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity. Hepatology (2009) 1.08
The genetic background modulates susceptibility to mouse liver Mallory-Denk body formation and liver injury. Hepatology (2008) 1.07
Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement. Gastroenterology (2007) 1.07
Keratin mutation predisposes to mouse liver fibrosis and unmasks differential effects of the carbon tetrachloride and thioacetamide models. Gastroenterology (2008) 1.07
Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritis. Am J Med (2002) 1.06
Keratin 8 overexpression promotes mouse Mallory body formation. J Cell Biol (2005) 1.04
Organ-specific stress induces mouse pancreatic keratin overexpression in association with NF-kappaB activation. J Cell Sci (2004) 1.04
Keratin 8 phosphorylation regulates keratin reorganization and migration of epithelial tumor cells. J Cell Sci (2012) 1.04
Keratins modulate the shape and function of hepatocyte mitochondria: a mechanism for protection from apoptosis. J Cell Sci (2009) 1.04
Diagnosis, comorbidities, and management of irritable bowel syndrome in patients in a large health maintenance organization. Clin Gastroenterol Hepatol (2011) 1.01
Keratin hypersumoylation alters filament dynamics and is a marker for human liver disease and keratin mutation. J Biol Chem (2010) 1.00
Wnt/β-catenin signaling protects mouse liver against oxidative stress-induced apoptosis through the inhibition of forkhead transcription factor FoxO3. J Biol Chem (2013) 1.00
Keratin mutation primes mouse liver to oxidative injury. Hepatology (2005) 1.00
Analysis of keratin polypeptides 8 and 19 variants in inflammatory bowel disease. Clin Gastroenterol Hepatol (2007) 1.00
Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies. Proc Natl Acad Sci U S A (2003) 1.00
Utilization and antiviral therapy in patients with chronic hepatitis C: analysis of ambulatory care visits in the US. Dig Dis Sci (2010) 0.99
Identification of cytokeratins as accessory mediators of Salmonella entry into eukaryotic cells. Life Sci (2002) 0.98
A mutation of keratin 18 within the coil 1A consensus motif causes widespread keratin aggregation but cell type-restricted lethality in mice. Exp Cell Res (2007) 0.96
Raf-1 activation disrupts its binding to keratins during cell stress. J Cell Biol (2004) 0.95
Clinical and economic burden of emergency department visits due to gastrointestinal diseases in the United States. Am J Gastroenterol (2013) 0.94
Keratin 20 serine 13 phosphorylation is a stress and intestinal goblet cell marker. J Biol Chem (2006) 0.94
Absence of keratin 8 confers a paradoxical microflora-dependent resistance to apoptosis in the colon. Proc Natl Acad Sci U S A (2011) 0.94
Mouse hepatocyte overexpression of NF-κB-inducing kinase (NIK) triggers fatal macrophage-dependent liver injury and fibrosis. Hepatology (2014) 0.93
Proximal and distal colorectal cancer resection rates in the United States since widespread screening by colonoscopy. Gastroenterology (2012) 0.91
Bispecific and human disease-related anti-keratin rabbit monoclonal antibodies. Exp Cell Res (2005) 0.91
Fibrinogen-γ proteolysis and solubility dynamics during apoptotic mouse liver injury: heparin prevents and treats liver damage. Hepatology (2011) 0.90
p38 MAP kinase and MAPKAP kinases MK2/3 cooperatively phosphorylate epithelial keratins. J Biol Chem (2010) 0.90
Mallory-Denk bodies are associated with outcomes and histologic features in patients with chronic hepatitis C. Clin Gastroenterol Hepatol (2011) 0.90
Keratin-8 null mice have different gallbladder and liver susceptibility to lithogenic diet-induced injury. J Cell Sci (2003) 0.89
Keratin overexpression levels correlate with the extent of spontaneous pancreatic injury. Am J Pathol (2008) 0.89
Rescue of atypical protein kinase C in epithelia by the cytoskeleton and Hsp70 family chaperones. J Cell Sci (2009) 0.89
Reg-II is an exocrine pancreas injury-response product that is up-regulated by keratin absence or mutation. Mol Biol Cell (2007) 0.88
GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded endpoint (PROBE) trial. Am J Gastroenterol (2013) 0.88
Protein phosphatase-2A associates with and dephosphorylates keratin 8 after hyposmotic stress in a site- and cell-specific manner. J Cell Sci (2006) 0.88
Lamin aggregation is an early sensor of porphyria-induced liver injury. J Cell Sci (2013) 0.87
Improvement of disease activity of rheumatoid arthritis patients from 2000 to 2006 in a large observational cohort study IORRA in Japan. Mod Rheumatol (2007) 0.87
Increased co-first authorships in biomedical and clinical publications: a call for recognition. FASEB J (2013) 0.87
The NIH, research institutions and industry: working together on a shared goal. Gastroenterology (2007) 0.87
"Toxic memory" via chaperone modification is a potential mechanism for rapid Mallory-Denk body reinduction. Hepatology (2008) 0.87
Mentoring the mentor: another tool to enhance mentorship. Gastroenterology (2008) 0.86
Toll like receptor 3 plays a critical role in the progression and severity of acetaminophen-induced hepatotoxicity. PLoS One (2013) 0.86
Actin overexpression parallels severity of pancreatic injury. Exp Cell Res (2004) 0.86
Heme oxygenase-1 is induced in peripheral blood mononuclear cells of patients with acute pancreatitis: a potential therapeutic target. Am J Physiol Gastrointest Liver Physiol (2010) 0.86
Keratin 8 phosphorylation regulates its transamidation and hepatocyte Mallory-Denk body formation. FASEB J (2012) 0.86
Proteasome inhibition induces inclusion bodies associated with intermediate filaments and fragmentation of the Golgi apparatus. Exp Cell Res (2003) 0.86
Denaturing temperature selection may underestimate keratin mutation detection by DHPLC. Hum Mutat (2006) 0.86
Oxidative stress, Nrf2 and keratin up-regulation associate with Mallory-Denk body formation in mouse erythropoietic protoporphyria. Hepatology (2012) 0.86
Treatment persistency with rivastigmine and donepezil in a large state medicaid program. J Am Geriatr Soc (2005) 0.85
Glucose and SIRT2 reciprocally mediate the regulation of keratin 8 by lysine acetylation. J Cell Biol (2013) 0.85
The hypoxia-inducible factor-C/EBPα axis controls ethanol-mediated hepcidin repression. Mol Cell Biol (2012) 0.85
Pharmacologic transglutaminase inhibition attenuates drug-primed liver hypertrophy but not Mallory body formation. FEBS Lett (2006) 0.84
Unique amino acid signatures that are evolutionarily conserved distinguish simple-type, epidermal and hair keratins. J Cell Sci (2012) 0.84
Incidence and risk of intestinal and extra-intestinal complications in Medicaid patients with inflammatory bowel disease: a 5-year population-based study. Dig Dis Sci (2010) 0.84
Mutation of caspase-digestion sites in keratin 18 interferes with filament reorganization, and predisposes to hepatocyte necrosis and loss of membrane integrity. J Cell Sci (2014) 0.84
Keratin 8 modulates β-cell stress responses and normoglycaemia. J Cell Sci (2013) 0.83